Original Research

JCP
Intravenous Scopolamine Versus Active Placebo in MDD
PCC
Computer Vision Syndrome, Insomnia, and Migraine
JCP
Remission of Psychotic Late-Life Depression Following ECT
PCC
Substance Abuse and Metabolic Syndrome
JCP
Faces Scales to Measure Anxiety and Anger
JCP
Very Low-Level Transcranial Photobiomodulation for MDD
JCP
Cannabidiol for Treatment-Resistant Anxiety
JCP
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics
JCP
Add-on Pramipexole for Schizophrenia
JCP
Depression Severity, Psychotic Depression, and Suicide Risk
JCP
Predictors of Recurrence or Persistence in Panic Disorder
PCC
Suicidal Behaviors Among Youth
JCP
Amphetamine Extended-Release Tablets for Adult ADHD
JCP
Treatment-Resistant Mood Disorders in LGBTQ People
PCC
Criminal Behavior in Bipolar I Disorder
PCC
Vaccination Among Children With Developmental Delay and Their Siblings
JCP
Elevated CCK With ARFID
JCP
Sexual Health, Substance Use, and ADHD in College Students
PCC
Tardive Dyskinesia in a Community Mental Health Center
JCP
Toward A Definition Of “No Meaningful Benefit” From Antidepressant Treatment
JCP
Nocturnal Wakefulness and Suicide
JCP
Association of Bupropion and Opioid Use Disorder Medications With Stimulant-Related Admissions
PCC
Social Anxiety Among Lebanese Adolescents
JCP
Mental Pain, Suicide Risk, and Childhood Trauma